NASDAQ
BENF
Last Price
US $2.86
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Beneficient cash flow to debt ratio of -40.00% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Beneficient's free cash flow has increased -0.22% from $-38.80M last year to $-38.72M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Beneficient's debt to equity ratio is 1.07, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Beneficient's debt has increased relative to shareholder equity from -0.71 last year to 1.07 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Beneficient has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Beneficient's interest coverage ratio is -5.55, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
Beneficient's profit margin has increased (-123.57%) in the last year from -643.95% to 151.79%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Beneficient's short-term liabilities of $239.14M exceed its short-term assets of $2.54M, signaling financial risk
Decreasing performance - ROA.
Beneficient's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
Beneficient's return on equity of 65.74%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Beneficient's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Beneficient had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Beneficient has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Beneficient has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Beneficient's yearly earnings has decreased -270.88% since last year from $51.16M to $-87.43M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Beneficient's yearly revenue has decreased 392.45% since last year from $-7.95M to $-39.12M, signaling decreasing performance
Increasing performance - ROIC.
ROIC 31.65% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
Beneficient has insufficient revenue history to calculate 3-year revenue CAGR.
Decreasing performance - Revenue consistency.
Beneficient had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Decreasing performance - ROE consistency.
Beneficient had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Beneficient has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Beneficient has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Beneficient is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Beneficient has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Beneficient has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Beneficient has negative shareholder equity; price-to-book is not meaningful and the check fails
Overvalued - P/S ratio.
Beneficient has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-25.49%
Return on equity
ROIC: -
Valuation History
4.8X
Price to Earnings
EV/EBITDA: -
Cash flow
Profit margin
-33.96%
(FY vs FY)
Cash flow Y/Y
9.59%
(FY vs FY)
Fair Value
Market $2.86
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.